225 related articles for article (PubMed ID: 1673638)
21. Multidrug resistance mediated by P-glycoproteins.
Schinkel AH; Borst P
Semin Cancer Biol; 1991 Aug; 2(4):213-26. PubMed ID: 1680493
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.
Slovak ML; Hoeltge GA; Dalton WS; Trent JM
Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069
[TBL] [Abstract][Full Text] [Related]
23. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
[TBL] [Abstract][Full Text] [Related]
24. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
Mirski SE; Gerlach JH; Cole SP
Cancer Res; 1987 May; 47(10):2594-8. PubMed ID: 2436751
[TBL] [Abstract][Full Text] [Related]
25. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression.
Slapak CA; Daniel JC; Levy SB
Cancer Res; 1990 Dec; 50(24):7895-901. PubMed ID: 1979251
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the multidrug resistance protein expressed in cell clones stably transfected with the mouse mdr1 cDNA.
Schurr E; Raymond M; Bell JC; Gros P
Cancer Res; 1989 May; 49(10):2729-33. PubMed ID: 2565763
[TBL] [Abstract][Full Text] [Related]
27. Detection of soluble P-glycoprotein in culture media and extracellular fluids.
Chu TM; Lin TH; Kawinski E
Biochem Biophys Res Commun; 1994 Aug; 203(1):506-12. PubMed ID: 7915520
[TBL] [Abstract][Full Text] [Related]
28. Induced multidrug-resistance in murine sarcoma 180 cells grown in vitro and in vivo and associated changes in expression of multidrug-resistance DNA-sequences and membrane glycoproteins.
Volm M; Bak M; Efferth T; Mattern J
Anticancer Res; 1988; 8(6):1169-78. PubMed ID: 3218953
[TBL] [Abstract][Full Text] [Related]
29. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
[TBL] [Abstract][Full Text] [Related]
30. Detection of multidrug resistance markers, P-glycoprotein and mdr1 mRNA, in human leukemia cells.
Tsuruo T; Sugimoto Y; Hamada H; Roninson I; Okumura M; Adachi K; Morishima Y; Ohno R
Jpn J Cancer Res; 1987 Dec; 78(12):1415-9. PubMed ID: 2892823
[TBL] [Abstract][Full Text] [Related]
31. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice.
Mickisch GH; Pai LH; Gottesman MM; Pastan I
Cancer Res; 1992 Aug; 52(16):4427-32. PubMed ID: 1353705
[TBL] [Abstract][Full Text] [Related]
33. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.
Cordon-Cardo C; O'Brien JP; Boccia J; Casals D; Bertino JR; Melamed MR
J Histochem Cytochem; 1990 Sep; 38(9):1277-87. PubMed ID: 1974900
[TBL] [Abstract][Full Text] [Related]
34. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities.
Devault A; Gros P
Mol Cell Biol; 1990 Apr; 10(4):1652-63. PubMed ID: 1969610
[TBL] [Abstract][Full Text] [Related]
35. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
[TBL] [Abstract][Full Text] [Related]
36. Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein.
Schinkel AH; Arceci RJ; Smit JJ; Wagenaar E; Baas F; Dollé M; Tsuruo T; Mechetner EB; Roninson IB; Borst P
Int J Cancer; 1993 Sep; 55(3):478-84. PubMed ID: 8104165
[TBL] [Abstract][Full Text] [Related]
37. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells.
Zhao JY; Ikeguchi M; Eckersberg T; Kuo MT
Endocrinology; 1993 Aug; 133(2):521-8. PubMed ID: 8102093
[TBL] [Abstract][Full Text] [Related]
38. Characterization of multidrug-resistant pituitary tumor cells.
Nelson EJ; Hinkle PM
Endocrinology; 1992 Jun; 130(6):3246-56. PubMed ID: 1350759
[TBL] [Abstract][Full Text] [Related]
39. Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines.
Januchowski R; Wojtowicz K; Andrzejewska M; Zabel M
Biomed Pharmacother; 2014 Feb; 68(1):111-7. PubMed ID: 24140176
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical identification of P-glycoprotein in previously untreated, diffuse large cell and immunoblastic lymphomas.
Niehans GA; Jaszcz W; Brunetto V; Perri RT; Gajl-Peczalska K; Wick MR; Tsuruo T; Bloomfield CD
Cancer Res; 1992 Jul; 52(13):3768-75. PubMed ID: 1352183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
